10 results found.

Uveitis Clinical Trial using adalimumab; prednisone; adalimumab placebo

AbbVie - Recruiting 18 years or older.
- A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis.
adalimumab; prednisone; adalimumab placebo

Behcet's Disease, or Uveitis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Immunogenetic Mechanisms in Behcet's Disease.

Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), or Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years or older.
- Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases.

Uveitis Clinical Trial using Sarilumab SAR153191/REGN88; Prednisone; Methotrexate; Folic/folinic acid; Sarilumab (SAR153191/REGN88) placebo

Sanofi - Recruiting 18 years or older.
- A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU).
Sarilumab SAR153191/REGN88; Prednisone; Methotrexate; Folic/folinic acid; Sarilumab (SAR153191/REGN88) placebo

Posterior Uveitis, Intermediate Uveitis, or Panuveitis Clinical Trial using FAI insert; Sham injection

pSivida Corp. - Recruiting 18 years or older.
- A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye.
FAI insert; Sham injection

Uveitis, Vasculitis, or Ocular Inflammatory Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 80 years.
- The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease.

Uveitis Clinical Trial using adalimumab; prednisone; adalimumab placebo

AbbVie - Recruiting 18 years or older.
- A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate-, Posterior-, or Pan-uveitis.
adalimumab; prednisone; adalimumab placebo

Conjunctival Disease, Corneal Disease, Eye Disease, Uveitis, or V Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Immunopathology and Molecular Pathology of Ocular Diseases in Humans.

Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis, or Clinical Trial using triamcinolone acetonide (Triesencer)

Clearside Biomedical, Inc. - Recruiting 18 years or older.
- Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis.
triamcinolone acetonide (Triesencer)

Uveitis Clinical Trial

Oregon Health and Science University - Recruiting 21 years or older.
- .